Norman LaFrance, MD

Norman LaFrance, M.D., joined Y-mAbs as Chief Development Officer in June 2024. Dr. LaFrance brings over 40 years of deep radiopharmaceutical experience as both a nuclear medicine physician and pharmaceutical executive. He previously served as Chief Medical Officer, Senior Vice President of PLUS Therapeutics, Inc., and prior to that, as Chief Medical Officer at Jubilant Pharma Ltd. Earlier, Dr. LaFrance served as Global Chief Medical Officer at IBA Molecular and earlier, as Senior Vice President and Chief Medical Officer of Molecular Insight Pharmaceuticals, Inc. Dr. LaFrance practiced medicine and held academic faculty appointments at Johns Hopkins University School of Medicine. He is Double Board Certified with Fellowship status both in internal medicine and nuclear medicine. Dr. LaFrance received his B.S and Master of Engineering degrees in nuclear engineering and science from Rensselaer Polytechnic Institute, and his M.D. from the University of Arizona, College of Medicine, Tucson.